e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellectis S.A. - American Depositary Shares
(NQ:
CLLS
)
4.690
-0.090 (-1.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
117,408
Open
4.800
Bid (Size)
4.410 (6,400)
Ask (Size)
5.000 (1,000)
Prev. Close
4.780
Today's Range
4.545 - 4.860
52wk Range
1.100 - 5.480
Shares Outstanding
45,484,310
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Cellectis Stock Is Trading Higher Today
↗
November 19, 2025
Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.
Via
Benzinga
European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility
November 19, 2025
European American Depositary Receipts (ADRs) have recently experienced a period of significant fluctuation, reflecting a broader climate of market volatility that has ripple across global financial...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Supply Chain
Performance
YTD
+159.1%
+159.1%
1 Month
+30.6%
+30.6%
3 Month
+64.6%
+64.6%
6 Month
+219.0%
+219.0%
1 Year
+152.2%
+152.2%
More News
Read More
Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells
November 19, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Earnings Preview
↗
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
November 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Earnings Scheduled For November 7, 2025
↗
November 07, 2025
Via
Benzinga
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 03, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report Third Quarter Financial Results on November 7, 2025
October 31, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
October 20, 2025
Via
Benzinga
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
October 16, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Thursday's session: gap up and gap down stocks
↗
October 16, 2025
Via
Chartmill
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday
↗
October 16, 2025
Via
Benzinga
Top 2 Health Care Stocks That May Keep You Up At Night This Month
↗
October 16, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
↗
October 16, 2025
Via
Chartmill
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
October 16, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
October 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Wondering what's happening in today's pre-market session?
↗
September 29, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 29, 2025
Via
Benzinga
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 29, 2025
Via
Benzinga
Topics
Stocks
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
↗
September 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
September 19, 2025
Via
Benzinga
Top 5 Biotech Stocks With Strong Momentum
↗
August 28, 2025
Via
Benzinga
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
August 04, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
July 29, 2025
Via
Benzinga
Frequently Asked Questions
Is Cellectis S.A. - American Depositary Shares publicly traded?
Yes, Cellectis S.A. - American Depositary Shares is publicly traded.
What exchange does Cellectis S.A. - American Depositary Shares trade on?
Cellectis S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cellectis S.A. - American Depositary Shares?
The ticker symbol for Cellectis S.A. - American Depositary Shares is CLLS on the Nasdaq Stock Market
What is the current price of Cellectis S.A. - American Depositary Shares?
The current price of Cellectis S.A. - American Depositary Shares is 4.690
When was Cellectis S.A. - American Depositary Shares last traded?
The last trade of Cellectis S.A. - American Depositary Shares was at 11/21/25 04:00 PM ET
What is the market capitalization of Cellectis S.A. - American Depositary Shares?
The market capitalization of Cellectis S.A. - American Depositary Shares is 213.32M
How many shares of Cellectis S.A. - American Depositary Shares are outstanding?
Cellectis S.A. - American Depositary Shares has 213M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.